Evidence map›Paper›PMID 40429996›Full record

ReviewInternational journal of molecular sciences2025

Ketone Bodies in the Regulation of Myocardial Perfusion in Cardiovascular Disease: Metabolic and Vasodilatory Effects.

Afolasayo A Aromiwura, Kara R Gouwens, Daniel C Nguyen, Maryta Sztukowska, Luanne Didelot, Dinesh K Kalra

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Afolasayo A AromiwuraDivision of Cardiology, Department of Medicine, University of Louisville, Louisville, KY 40202, USA.
Kara R GouwensDepartment of Medicine, Christina Lee Brown Envirome Institute, Center for Cardiometabolic Science, University of Louisville, Louisville, KY 40202, USA.
Daniel C NguyenDepartment of Medicine, Christina Lee Brown Envirome Institute, Center for Cardiometabolic Science, University of Louisville, Louisville, KY 40202, USA.ORCID 0000-0002-9268-0300
Maryta SztukowskaDepartment of Medicine, College of Nursing, University of Information Technology and Management, 35-225 Rzeszów, Poland.ORCID 0000-0002-5774-5092
Luanne DidelotClinical Trials Unit, School of Medicine, University of Louisville, Louisville, KY 40202, USA.
Dinesh K KalraDivision of Cardiology, Department of Medicine, University of Louisville, Louisville, KY 40202, USA.ORCID 0000-0001-5254-4067

Funding

Fibroblast TAK1 signaling in cardiac fibrosisF30HL165813 · NHLBI · UNIVERSITY OF LOUISVILLE · PI NGUYEN, DANIEL · 2023 to 2025
$143k
American Heart Association 24DIVSUP1291349NHLBI NIH HHS F30 HL165813NIH HHS HL165813
6 · The paper itself

Abstract

Ketone bodies (KBs) serve as an alternative energy source for healthy and failing hearts and have important effects on myocardial blood perfusion in both physiological and pathological states. Early animal studies suggest that KBs may provide protective benefits in ischemic heart disease and heart failure. Under normal circumstances, coronary blood flow regulation is an intricate system with contributions from metabolic, autonomic, compressive, and endothelial factors, with the metabolic regulatory pathway being the most significant contributor. We conducted a non-systematic review of studies published between 1987 and 2024. In this review, we explored the physiological autoregulation of normal coronary blood flow, the role of ketone bodies in myocardial perfusion in health and disease, and the potential role of exogenous ketone body supplementation in producing salutary effects on myocardial blood flow (MBF) and metabolism in exercise and cardiac disease states including ischemia, heart failure, and the aging heart. Overall, our findings demonstrated that KBs improve MBF and ejection fraction in healthy human subjects and have beneficial effects on cardiac output and left heart filling pressures in patients with decompensated heart failure. Although resting myocardial blood flow decreases with age, further studies are required to assess the impact of KBs on MBF in aging populations. Additionally, more research is needed to investigate the effects of KBs during exercise and in instances of myocardial ischemia.

Indexed as

Cardiovascular DiseasesCoronary CirculationKetone BodiesMyocardiumVasodilationAnimalsHeart FailureHumansMyocardial IschemiaKetone Bodiesketone bodiesmetabolic vasodilationmyocardial blood flow

Identifiers

PMID40429996
PMCPMC12111909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.